Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S47445 in mild to moderate Alzheimer's disease with depressive symptoms (phase II)
2014-001519-38Phase 2Completed
- Sponsor
- Servier
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tulrampator in Alzheimer's disease (AD) and major depressive disorder (MDD) (4 arms), sponsored by Servier. Started Sep 2014; status: completed.
02
Drugs
tulrampator
03
Conditions
Alzheimer's disease (AD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2014-001519-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001519-38.